| ELUSYS THERAPEUTICS INC FKA NIGHTHAWK BIOSCIENCES, INC. | ELUSYS THERAPEUTICS INC FKA NIGHTHAWK BIOSCIENCES, INC. | Q3 2026 | Defense, Health Issues |
| NEUROTHERA LABS, INC. | RK STRATEGIES, INC. | Q3 2026 | Health Issues |
| BULLBAG CORPORATION | RK STRATEGIES, INC. | Q3 2026 | Disaster Planning/Emergencies, Waste (hazardous/solid/interstate/nuclear) |
| CLEARMIND MEDICINE, INC | RK STRATEGIES, INC. | Q3 2026 | Alcohol and Drug Abuse, Defense, Veterans |
| BREAKING BARRIERS TO SUBSTANCE USE RECOVERY | RK STRATEGIES, INC. | Q3 2026 | Alcohol and Drug Abuse, Veterans, Health Issues |
| ELSE NUTRITION GH LTD. | RK STRATEGIES, INC. | Q3 2026 | Food Industry (safety, labeling, etc.), Health Issues |
| THE RECOVERY PLATFORM | RK STRATEGIES, INC. | Q3 2026 | Alcohol and Drug Abuse, Veterans, Health Issues |
| RECCE PHARMACEUTICALS LTD | RK STRATEGIES, INC. | Q3 2026 | Defense, Veterans, Health Issues |
| NEXALIN TECHNOLOGY INC. | RK STRATEGIES, INC. | Q3 2026 | Defense, Veterans, Health Issues |
| IPILL, INC. | RK STRATEGIES, INC. | Q2 2026 | Alcohol and Drug Abuse, Veterans, Health Issues |
| ADIAL PHARMACEUTICALS, INC. | RK STRATEGIES, INC. | Q2 2026 | Defense, Health Issues |
| SCORPIUS BIOMANUFACTURING, INC. | RK STRATEGIES, INC. | Q3 2025 | Defense, Health Issues |